Esophageal Cancer · Endoscopic vs Esophagectomy

Step-by-step decision

Choose step by step as prompted; reaching an endpoint gives the management recommendation. You can go back a step or restart anytime.

Full pathway

1. [Decision] Stage (T/N/M)
   Depth of invasion/nodes/metastasis? Location and operability?
   • Tis/T1a (intramucosal) → Tis/T1a → endoscopic resection
   • T1b localized, operable → T1b → esophagectomy
   • Locally advanced T2-4a or N+, operable → Locally advanced → neoadjuvant then resection
   • Cervical SCC or inoperable → Cervical/inoperable → definitive chemoradiation
   • Metastatic → Metastatic → systemic + palliative
2. [End] Tis/T1a → endoscopic resection
   Tis/T1a intramucosal → endoscopic resection (EMR/ESD), en bloc + pathologic assessment of curativeness; non-curative (deep invasion/LVI+) → esophagectomy.
3. [End] T1b → esophagectomy
   T1b localized → esophagectomy (transthoracic Ivor-Lewis/McKeown or transhiatal; minimally invasive preferred) + lymphadenectomy; individualize for elderly/comorbidity.
4. [End] Locally advanced → neoadjuvant then resection
   Locally advanced T2-4a/N+ → neoadjuvant chemoradiation (CROSS) then esophagectomy; SCC may also have neoadjuvant chemotherapy/chemoradiation.
5. [End] Cervical/inoperable → definitive chemoradiation
   Cervical SCC or inoperable → definitive chemoradiation; dysphagia/obstruction → stent/nutritional support.
6. [End] Metastatic → systemic + palliative
   Metastatic → systemic therapy (chemotherapy ± immunotherapy/targeted) + palliation (stent to relieve obstruction, nutrition, pain).

Source guidelines & references

• Esophageal cancer management (NCCN; CROSS neoadjuvant chemoradiation)

This pathway is our own synthesis of the decision logic in the guidelines above (not the guideline verbatim); thresholds and workflows change as guidelines update — in practice follow the latest guideline, your institution's protocol and the individual patient.

Other pathways